- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02012023
Use of One Kind of Controllable Tube Ileostomy in the Low Rectal Cancer (CTI)
Use of One Kind of Controllable Tube Ileostomy to Protect Anastomotic Leakage in the Low Rectal Cancer.
Most surgeons suggest the use of fecal diverting to address the high morbidity and mortality associated with anastomotic leakage (AL) in patients with high risk factors on AL who are undergoing low anterior resections(LAR). This exploratory study was conducted to evaluate the efficacy and safety of one kind of controllable tube ileostomy(CTI), which was designed to protect rectal anastomosis in patients with high risk factors on AL. Results of SCCI were compared to those of the loop ileostomy (LI) method.
In fact when we told the patients about the tube ileustomy's effect and risk, almost all the almost all of my patients like to choose tube ileustomy(I have study this method for long time and have good expeience, and my patients either choose tube ileostomy directly or let me do the choice.) So I gave all the patients who meet the requirenments all tube ileustomy and have no control group.
Study Overview
Status
Conditions
Detailed Description
After low anterior resection(LAR), a double row of concentric purse-string sutures were placed in the ileum wall using 3-0 absorbable suture. The diameters of the purse-string rings were about 10 mm and 20 mm, respectively. The investigators then made a small incision within the inner purse-string and inserted the trachea cannula into the proximal end of the ileum. The inner purse-string suture then was tied, followed by the outer purse-string suture. The outer purse string should capsulate the inner purse string to prevent leakage. Normal saline was injected into the air bag until the ileum wall. The investigators will test the pressure of airbag, and control the pressure of airbag from 30-40cmHg. The investigators then pulled the cannula out through the abdominal wall. The incision site in the ileum was approximated to the inner abdominal wall and extraperitonized by fixing the mobilized ileum wall around the cannula to the inner abdominal wall. This was accomplished using 3-4 interrupted sutures.
In the CTI group, the tube will be removed after 3-4 weeks. If anastomotic leakage occurred, the investigators will test the airbag pressure and keep the pressure during 30-40cmHg. Because with time went on, the ileum will dilated , the airbag pressure will go down, then the feces may go through the airbag plane and flow into colon and the tube ileostomy will lose its defunctioning effect.When the investigators control the airbag pressure, we can control the defunctioning effect of tube stomy. So it is called controllable tube ileostomy. The investigators will keep the tube until the anastomotic leakage was cured.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zhejiang
-
Hangzhou,, Zhejiang, China, 310003
- Department of Colorectal Surgery, First Affiliated Hospital, Zhejiang University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Rectal Tumor After Low Anterior Resection the Anastomosis Located extraperitoneal
- Patients Agreed to Undergo the tube ileostomy or loop ileostomy Procedure
Exclusion Criteria:
- Bowel Preparation is not Satisfied Before Operation
- Blood lose is more than 1500ml during operation
- Critical incident during operation
- The vagina or bladder is seriously damaged and the fix is not satisfied.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Controllable tube ileostomy
After LAR, the experimental group accepted controllable tube ileostomy.
|
|
|
Active Comparator: Loop ileostomy
After LAR, the experimental group accepted loop ileostomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anastomotic leakage
Time Frame: about in 3 months after operaion
|
Anastomotic leakage(AL) is the main complication after LAR.AL is defined as a defect of intestinal wall integrity at the colorectal or coloanal anastomotic site (including suture and staple lines of the neorectal reservoirs) leading to communication between intra- and extraluminal compartments.
|
about in 3 months after operaion
|
|
reoperation rate
Time Frame: about 3 months after operation
|
When AL occurred, whether this patient need reoperation is determined by the clinical manifestation.
Reoperation rate and mortality are two key index to evaluate the effect and safety of cannula ileostomy.
|
about 3 months after operation
|
|
mortality
Time Frame: about 3 months after operation
|
about 3 months after operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ileus rate
Time Frame: during the follow time(about 6 months after operaion)
|
Another main operation complication was intestinal obstruction.
Ileus conclude two types: temporally ileus and intractable ileus.
Temporally ileus can be treated by conservative treatment and intractable ileus need reoperation.Ileus usually is caused by intestinal adhesion.
But in CTI group, ileus maybe caused by the cannula obstruction.
|
during the follow time(about 6 months after operaion)
|
|
operation data
Time Frame: durting the operation time (about 1-5 h)
|
including operation method, time, blood loss et al.
|
durting the operation time (about 1-5 h)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
hospital stays
Time Frame: from admission time to discharge time(about 7-14days)
|
In loop ileostomy group, hospital stays and costs include the readmission to close the stoma.
|
from admission time to discharge time(about 7-14days)
|
|
hospital costs
Time Frame: from admission time to discharge time(about 7-14days)
|
In loop ileostomy group, hospital stays and costs include the readmission to close the stoma.
|
from admission time to discharge time(about 7-14days)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hua Hanju, Doctor, Zhejiang University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Controllable tube ileostomy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectal Neoplasms
-
University of EdinburghNHS LothianNot yet recruitingRectal Cancer | Bowel Cancer | Rectal Adenocarcinoma | Polyp Rectal | Rectal AdenomaUnited Kingdom
-
Jagiellonian UniversityNot yet recruitingRectal Cancer | Rectal Adenocarcinoma | Rectal Adenoma | Recurrent Rectal Adenocarcinoma | Rectal Neuroendocrine NeoplasmPoland
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
Colospan Ltd.RecruitingRectal Cancer | Rectal Tumor | Rectal/AnalUnited States, Israel, Italy
-
SafeHeal IncTerminatedSafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study (SAFE-2)Colorectal Cancer | Rectal Cancer | Rectal Tumor | Rectal/AnalUnited States, France, Belgium
-
Sahlgrenska University HospitalGöteborg UniversityNot yet recruitingRectal Cancer | Rectal Cancer Patients | Rectal Cancer Surgery | Rectal Cancer, RadiotherapySweden
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Rectal AdenocarcinomaUnited States
-
Turkish Society of Colon and Rectal SurgeryBaskent University; Dokuz Eylul University; Halic University; Acibadem Kent Hospital and other collaboratorsNot yet recruitingRectal Cancer Stage II | Rectal Cancer Stage III | Mid-Rectal CancerTurkey
-
University of California, DavisNational Cancer Institute (NCI)Not yet recruitingRectal Cancer | Rectal Adenocarcinoma | Locally Advanced Rectal Adenocarcinoma | Early-stage Rectal CancerUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Taiho Pharmaceutical Co., Ltd.Active, not recruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8United States
Clinical Trials on loop ileostomy
-
University Hospital, AngersUnknownEnterocolitis, Necrotizing | Intestinal Obstruction | Gastroschisis | Hirschsprung DiseaseFrance
-
Helsinki University Central HospitalMary and Georg Ehrnrooth's foundation; Helsinki University Hospital Research...Not yet recruitingStoma Ileostomy | Stoma ColostomyFinland
-
University Hospital Inselspital, BerneTerminated
-
SafeHeal IncCompletedColorectal Cancer | Stoma IleostomyUnited States, France, Belgium, Italy
-
Evangelisches Klinikum Köln Weyertal gGmbHUniversity of CologneCompletedColorectal SurgeryGermany
-
First Affiliated Hospital of Zhejiang UniversityUnknownRectal NeoplasmsChina
-
Russian Society of Colorectal SurgeonsCompleted
-
Jewish General HospitalTerminatedFulminant Clostridium Difficile ColitisCanada
-
Institut d'Investigació Biomèdica de Girona Dr....Completed
-
University of GuadalajaraCompleted